Hodgkin Lymphoma Clinical Trials in Shanghai, Shanghai Municipality
11 recruitingShanghai, Shanghai Municipality, China
Showing 1–11 of 11 trials
Recruiting
Phase 1
A Study to Evaluate MK-1045 (CN201) in Participants With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (MK-1045-001/CN201-101)
Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
MSD R&D (China) Co., Ltd.100 enrolled15 locationsNCT06189391
Recruiting
Phase 2Phase 3
Chemotherapy With Rituximab for Aggressive B-NHL in Children and Adolescents
Mature B-cell Non-Hodgkin Lymphoma
Children's Cancer Group, China87 enrolled1 locationNCT07168980
Recruiting
Early Phase 1
A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma(NHL)
Non-hodgkin Lymphoma,B Cell
Shanghai Cell Therapy Group Co.,Ltd20 enrolled1 locationNCT06446128
Recruiting
Phase 1
A Study of GLB-002 in Patients With Relapsed or Refractory Non-Hodgkin Lymphomas
Non-Hodgkin Lymphoma
Hangzhou GluBio Pharmaceutical Co., Ltd.110 enrolled13 locationsNCT06219356
Recruiting
Phase 1
A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (B-NHL)
B-cell Non Hodgkin Lymphoma
Ruijin Hospital56 enrolled1 locationNCT07072169
Recruiting
Phase 1Phase 2
CD7 CAR T-Cell Therapy for r/r T-cell Lymphomas
T-cell Non-Hodgkin LymphomaT-cell Lymphoma (PTCL and CTCL)
Beijing GoBroad Hospital36 enrolled4 locationsNCT06925464
Recruiting
Phase 1Phase 2
Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader
Non-Hodgkin LymphomaMantle Cell LymphomaFollicular Lymphoma+6 more
BeiGene146 enrolled29 locationsNCT05294731
Recruiting
Phase 1Phase 2
Safety and Efficacy of EX103 in Subjects with Relapsed/Refractory CD20-Positive Non-Hodgkin Lymphoma
CD20-positive Non-Hodgkin Lymphoma
Guangzhou Excelmab Inc.415 enrolled4 locationsNCT06021678
Recruiting
Phase 1
A Clinical Study Exploring CT1190B in the Treatment of Patients with Relapsed/refractory B-cell Non-Hodgkin Lymphoma
B-cell Non Hodgkin Lymphoma
Aibin Liang，MD，Ph.D.24 enrolled1 locationNCT06734871
Recruiting
The Pathogenesis and Prognostic Factors of Lymphoma
Hodgkin LymphomaNon-Hodgkin LymphomaLymphoma
Shanghai Zhongshan Hospital2,000 enrolled1 locationNCT06203652
Recruiting
Phase 1Phase 2
Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma
Refractory or Relapsed B-cell Non-Hodgkin Lymphoma
Aibin Liang，MD，Ph.D.48 enrolled1 locationNCT05842707